House committee advances another PBM reform bill that would ban spread pricing
The House Committee on Oversight and Accountability on Tuesday advanced legislation that would ban some common practices of pharmacy benefit managers — the middlemen who negotiate drug prices on behalf of insurers.
The bill, called the Delinking Revenue from Unfair Gouging (DRUG) Act, would require certain PBMs that contract with a carrier offering federal health benefits plans to “de-link” the fees they charge insurers from the price of drugs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.